However, whether the CYP2C19 metabolizer status affects the occurrence of PPI-induced thrombocytopenia has not been reported, and none of the cases included in this study mentioned patients’ CYP2C19 genotyping. Here, CYP2C19 is linked to Thrombocytopenia.